Skip to main content
. 2022 Jan 25;13(2):216. doi: 10.3390/genes13020216
EC endometrial cancer
EMT epithelial—mesenchymal transition
TCGA The Cancer Genome Atlas
GEO Gene Expression Omnibus
EPHB2 EPH receptor B2
TUFT1 tuftelin 1
CDKN2A cyclin-dependent kinase inhibitor 2A
ONECUT2 one cut homeobox 2
RBP2 retinol-binding protein 2
KLF8 Kruppel-like factor 8
E2F1 E2F transcription factor 1
SIX1 SIX homeobox 1
ERBB2 Erb-b2 receptor tyrosine kinase 2
RS risk score
ESTIMATE estimation of stromal and immune cells in malignant tumor tissues using expression data
ICB immune checkpoint blockade
TIDE tumor immune dysfunction and exclusion
GDSC Genomics of Drug Sensitivity in Cancer
ERGs EMT-related genes
UCEC uterine corpus endometrial carcinoma
ROC receiver-operating characteristic
TME tumor microenvironment
LASSO least absolute shrinkage and selection operator
IC50 the half-maximal inhibitory concentration
FDR false discovery rate
MMRd mismatch repair-deficient
CTLA-4 cytotoxic T-lymphocyte antigen 4
PD-L1 programmed cell death-ligand 1
FIGO The International Federation of Gynecology and Obstetrics
AUC area under the curve
OS overall survival
DFS disease-free survival